Table 5.
Altered neurotrophin and neurotrophin receptor expression in PD and DLB frontal cortex
| mRNA | CONTROL | PD | DLB | |||
|---|---|---|---|---|---|---|
| TrkA | 0.372 | ±0.041 | 0.185 | ±0.055 | 0.058 | ±0.017*** |
| TrkB | 97.05 | ±15.36 | 108.3 | ±87.55 | 15.88 | ±5.794** |
| p75NGF | 3.749 | ±0.945 | 3.056 | ±0.785 | 3.15 | ±0.979 |
| BDNF | 32.28 | ±3.203 | 10.48 | ±3.094* | 22.79 | ±4.254 |
| NGF | 25.3 | ±5.394 | 2.47 | ±0.436*** | 6.63 | ±2.761** |
Trk-tyrosine kinase receptor; p75NGF-low affinity NGF receptor; BDNF-brain derived neurotrophic factor; NGF-nerve growth factor. Gene expression was measured by qRT-PCR analysis with values (×10−9) normalized to 18S rRNA measured in parallel reactions. Inter-group comparisons were made using repeated measures ANOVA with the post hoc Dunn's multiple comparison test.
P<0.05,
P<0.01,
P<0.005 relative to control;
P<0.05 or better relative to PD.